selecting between anti-cd20 bispecific antibodies and anti-cd19 car t-cells in third-line nhl
Published 2 weeks ago • 82 plays • Length 3:26Download video MP4
Download video MP3
Similar videos
-
1:34
how will bispecifics impact the treatment of nhl?
-
2:43
bispecific antibodies for non-hodgkin lymphoma
-
3:49
the challenges in developing bispecific antibodies for non-hodgkin lymphoma
-
1:20
a comparison of bispecific antibodies emerging in multiple myeloma
-
1:16:35
bi-and tri-specific antibodies in non-hodgkin lymphoma: current data and perspectives
-
16:07
evolving role of bispecific antibodies in b-cell non-hodgkin lymphomas (b-nhl)
-
4:26
what are bispecific antibodies?
-
5:47
phase i study of cd20-tcb, a novel t-cell-engaging bispecific antibody, in r/r nhl
-
5:01
lymphocyte antigen receptor diversity | medical school companion
-
5:13
emerging immunotherapy treatments for b-cell non-hodgkin's lymphoma: bispecific antibodies
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
3:41
understanding bispecific antibodies
-
0:55
what are bispecific antibodies?
-
38:40
bispecific antibodies in lymphoma: an update
-
1:26:46
intro to immunity & antibodies (labs 20 & 21)
-
1:34
dr. smith discusses double-hit and triple-hit lymphoma
-
14:00
what are bispecific antibodies?
-
1:01:08
bispecific antibodies in lymphoma
-
23:13
bispecific antibodies in multiple myeloma | dana-farber cancer institute
-
22:25
simplified who classification of lymphoma by dr niyati